His Bundle Pacing 360 Degrees-Long Term Data Behind HBP — Lead Longevity and Physiologic Impact on Cardiac Function (Presenter: Gaurav A. Upadhyay, MD, FHRS)

Long Term Data Behind HBP — Lead Longevity and Physiologic Impact on Cardiac Function (Presenter: Gaurav A. Upadhyay, MD, FHRS)

Back to course

Video Transcription

Video Summary

Gaurav Upadhyay from the University of Chicago Medicine discussed the long-term data and impact of His bundle pacing. He mentioned that His bundle pacing can be achieved in over 80% of patients using modern tools, but there are certain risks associated with it. The lead used for His bundle pacing, the 3830 lead, has been shown to have increased pacing thresholds compared to conventional leads. However, studies have shown that the lead has a favorable safety profile and a freedom from complications up to eight years of follow-up. In terms of its impact on physiology, His bundle pacing has been associated with a reduction in a composite endpoint of death, heart failure, hospitalization, or upgrade to biventricular pacing. It has also been recommended for patients with low or moderately reduced ejection fraction and AV node block. The success rate of His bundle pacing for QRS correction varies depending on the pathophysiology, but recent studies have shown promising results with long-term follow-up showing improvement in left ventricular ejection fraction.

Meta Tag

Lecture ID 5336

Location Room 155

Presenter Gaurav A. Upadhyay, MD, FHRS

Role Invited Speaker

Session Date and Time May 09, 2019 4:30 PM - 6:00 PM

Session Number S-039

Keywords

University of Chicago Medicine

His bundle pacing

3830 lead

physiology impact

QRS correction